Page last updated: 2024-08-18

thiophenes and sanorg 34006

thiophenes has been researched along with sanorg 34006 in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haas, S; Kubitza, D	1
Gross, PL; Weitz, JI	1
Harenberg, J; Wehling, M	1
Spyropoulos, AC	1
Arya, R; Roberts, LN	1
Eikelboom, J; O'Donnell, M; Sobieraj-Teague, M	1
Godier, A; Samama, CM	1
Banda, ZK; Benmira, S; Bhattacharya, V	1
Morris, TA	1
Keltai, K; Keltai, M	1

Reviews

9 review(s) available for thiophenes and sanorg 34006

Article	Year
Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:8 Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Injections, Intravenous; Injections, Subcutaneous; Morpholines; Naphthalenes; Oligosaccharides; Polysaccharides; Propionates; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thromboembolism	2006
New anticoagulants for treatment of venous thromboembolism. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:3 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Male; Maximum Tolerated Dose; Morpholines; Oligosaccharides; Postphlebitic Syndrome; Prognosis; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Survival Analysis; Thiophenes; Treatment Outcome; Venous Thromboembolism	2008
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Seminars in thrombosis and hemostasis, 2008, Volume: 34, Issue:1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Glycine; Humans; Infusions, Parenteral; Morpholines; Oligosaccharides; Piperazines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Venous Thromboembolism	2008
Brave new world: the current and future use of novel anticoagulants. Thrombosis research, 2008, Volume: 123 Suppl 1 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Discovery; Factor Xa Inhibitors; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism	2008
New anticoagulants for prevention and treatment of venous thromboembolism. Current vascular pharmacology, 2010, Volume: 8, Issue:3 Topics: Animals; Anticoagulants; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Drugs, Investigational; Humans; Morpholines; Oligosaccharides; Pyridines; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism	2010
New anticoagulants for atrial fibrillation. Seminars in thrombosis and hemostasis, 2009, Volume: 35, Issue:5 Topics: Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Vitamin K	2009
[A new deal with new anticoagulants?]. Journal des maladies vasculaires, 2010, Volume: 35, Issue:3 Topics: Anticoagulants; Antithrombins; Factor Xa Inhibitors; Fondaparinux; Humans; Morpholines; Oligosaccharides; Polysaccharides; Rivaroxaban; Thiophenes	2010
Old versus new anticoagulants: focus on pharmacology. Recent patents on cardiovascular drug discovery, 2010, Volume: 5, Issue:2 Topics: Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Oligosaccharides; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Warfarin	2010
New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors. Clinics in chest medicine, 2010, Volume: 31, Issue:4 Topics: Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Fondaparinux; Humans; Morpholines; Oligosaccharides; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism	2010

Other Studies

1 other study(ies) available for thiophenes and sanorg 34006

Article	Year
[New anticoagulants in the prevention and treatment of venous thromboembolism]. Orvosi hetilap, 2011, Jun-19, Volume: 152, Issue:25 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Costs; Drugs, Investigational; Factor Xa Inhibitors; Humans; Hungary; Morpholines; Oligosaccharides; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism	2011

Article

Year

[New anticoagulants in the prevention and treatment of venous thromboembolism].

Orvosi hetilap, 2011, Jun-19, Volume: 152, Issue:25

Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Costs; Drugs, Investigational; Factor Xa Inhibitors; Humans; Hungary; Morpholines; Oligosaccharides; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism

2011